NCT03606837View on ClinicalTrials.gov

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

June 15, 2023

Study Completion Date

July 11, 2023

Conditions
Prostate Cancer
Interventions
DRUG

68Ga-PSMA-617 PET/CT

PET/CT Imaging with 68Ga-PSMA-617 injection

DRUG

68Ga-RM2 PET/CT

PET/CT Imaging with 68Ga-RM2 injection

Trial Locations (1)

33079

Bordeaux University Hospital, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03606837 - 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging | Biotech Hunter | Biotech Hunter